1. Posterior reversible encephalopathy syndrome possibly induced by pemetrexed maintenance therapy for lung cancer: a case report and literature review
   Gert-Jan Smets et al, 2017, Acta Clinica Belgica CrossRef
2. A Case of Posterior Reversible Encephalopathy Syndrome Induced by Cisplatin/Pemetrexed Chemotherapy for Lung Cancer
   Masashi Ishihara et al, 2017, Case Reports in Oncology CrossRef
3. Antiepileptic Drugs and Chemotherapy: Potential Interactions and Impact on Treatment of Patients With Cancer
   Karen L. Fink et al, 2018, Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy CrossRef
4. Magnetic resonance imaging of leukoencephalopathy in amnestic workers exposed to organotin
   Eunmi Lee et al, 2016, NeuroToxicology CrossRef
5. Posterior reversible encephalopathy syndrome with colitis in a patient treated with panitumumab
   Céline Blaye et al, 2017, Therapeutic Advances in Drug Safety CrossRef
6. Atypical posterior reversible encephalopathy syndrome associated with Lenvatinib therapy in a patient with metastatic thyroid cancer—A case report
   Mahajan Abhishek et al, 2022, Cancer Reports CrossRef
7. Leucoencéphalopathie postérieure réversible post-chimiothérapie par carboplatine et paclitaxel
   Mathieu Jamelot et al, 2019, Bulletin du Cancer CrossRef
8. Delayed Posterior Reversible Leukoencephalopathy Syndrome Triggered by FLOT Chemotherapy
   Jordi Gandini et al, 2020, Frontiers in Neurology CrossRef
9. Complex Metal Ions: Neuropsychiatric and Imaging Features
   James R. Bateman et al, 2020, The Journal of Neuropsychiatry and Clinical Neurosciences CrossRef
10. Posterior Reversible Encephalopathy Syndrome after Lenvatinib Therapy in a Patient with Anaplastic Thyroid Carcinoma
    Yoko Osawa et al, 2018, Internal Medicine CrossRef